[Answered] If you are simulating an M/M/1 queuing system with arrivals/hour and customers/hour then the ...

This topic contains a solution. Click here to go to the answer

« previous next »

Author Question: If you are simulating an M/M/1 queuing system with arrivals/hour and customers/hour then the ... (Read 62 times)

Kthamas

Hero Member
Posts: 546

on: Aug 1, 2018

If you are simulating an M/M/1 queuing system with

arrivals/hour and

customers/hour then the arrival rate input to Process Model will have what form?
a.P(1)
b.E(2)
c.E(30)
d.P(60)

Question 2

Which measure is not tracked on-screen?
a.Value Added Time
b.quantity processed
c.Waiting time
d.Cycle Time

Need homework help now?

Ask unlimited questions for free

Ask a Question

Marked as best answer by a Subject Expert

Sarahjh

Sr. Member
Posts: 370

Reply #1 on: Aug 1, 2018

Answer to Question 1

correct: b

Answer to Question 2

correct: c

Kthamas

Member
Posts: 546

Reply 2 on: Aug 1, 2018

Excellent

nyrave

Member
Posts: 344

Reply 3 on: Yesterday

Gracias!

« previous next »

Did you know?

Medication errors are more common among seriously ill patients than with those with minor conditions.

Did you know?

In the United States, congenital cytomegalovirus causes one child to become disabled almost every hour. CMV is the leading preventable viral cause of development disability in newborns. These disabilities include hearing or vision loss, and cerebral palsy.

Did you know?

Women are two-thirds more likely than men to develop irritable bowel syndrome. This may be attributable to hormonal changes related to their menstrual cycles.

Did you know?

Oxytocin is recommended only for pregnancies that have a medical reason for inducing labor (such as eclampsia) and is not recommended for elective procedures or for making the birthing process more convenient.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.